ArriVent BioPharma, Inc. AVBP Software and Technology Licenses, Net
Software and Technology Licenses, Net at other companies
Other financials
Where this comes from
Reported directly by ArriVent BioPharma, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: ArriVent BioPharma, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about ArriVent BioPharma, Inc.'s software and technology licenses, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ArriVent BioPharma, Inc.'s software and technology licenses, net?
- ArriVent BioPharma, Inc. (AVBP) reported software and technology licenses, net of $156K in Q1 2026.
- How has ArriVent BioPharma, Inc.'s software and technology licenses, net changed year-over-year?
- ArriVent BioPharma, Inc.'s software and technology licenses, net decreased by 11.4% year-over-year, from $176K to $156K.
- What is the long-term trend for ArriVent BioPharma, Inc.'s software and technology licenses, net?
- Over 2 years (2023 to 2025), ArriVent BioPharma, Inc.'s software and technology licenses, net has grown at a 33.3% compound annual growth rate (CAGR), from $107K to $190K.